Another Remission Story from Dr. Makis — Stage 4 Melanoma Survivor

Stuart Briscoe shared a powerful case from Dr. William Makis, describing a Canadian patient with Stage 4 melanoma and extensive liver metastases who was told he had just 2–3 days to live. The patient’s liver was “completely taken over” with cystic and solid lesions, yet he began a regimen of ivermectin, fenbendazole, and mebendazole — and within two months, most metastases had shrunk or disappeared.

The post sparked a multi-layered discussion — from dosing details and brand preferences to broader conversations about the clash between “evidence-based medicine” and the lived experiences of patients seeking alternative protocols.

✅ Key Protocol Components Shared

Makis Clinic Protocol (used in the case):
Stuart explained he splits his doses into smaller amounts across the day to maintain peak serum levels for longer.
Discussion about titrating doses — starting higher (some patients reportedly used up to 2.5mg/kg ivermectin) until scans showed regression, then tapering.
Mention of mixing fenbendazole with fats (yogurt, olive oil, butter) to boost absorption.
Brand considerations: Stuart likes US-manufactured tablets but rotates between FenBenLab, Wormentel, and Indian sources, echoing Dr. Makis’ recommendation to mix brands.

✅ Scientific & Philosophical Insights

Stuart framed the case as proof against the claim that fenbendazole damages the liver — pointing out that it was used successfully in a patient with liver failure.
John Brebeuf Garcia voiced frustration with medical professionals at MD Anderson who dismiss ivermectin, fenbendazole, and mebendazole as “not evidence-based,” noting how these attitudes can drain hope and energy from patients exploring alternatives.
This led to a deeper philosophical exchange:
The discussion even touched on faith and humility — “no atheists in a foxhole” — with several members noting how life-threatening illness often deepens spiritual reflection.

✅ Practical Wisdom from Community

Absorption & dosing tips: Splitting doses, taking fenbendazole with fats, and rotating brands to avoid reliance on one supplier.
Quality checks: Members suggested reading Amazon reviews and mixing manufacturers based on Dr. Makis’ clinical guidance.

✅ Resources & References Shared

Dr. Makis Substack post (Feb 17, 2025 testimonial).
Wikipedia link on Pelagianism (came up during a philosophical side conversation).

✅ Key Takeaways

Stunning case study: Ivermectin, fenbendazole, and mebendazole led to remission in a Stage 4 melanoma patient who was given just days to live.
Challenging medical orthodoxy: The thread shows the friction between mainstream oncology and patient-driven exploration — and how persistence can uncover life-saving alternatives.
Real-world dosing & sourcing tips: Splitting doses, taking fenbendazole with fats, and rotating brands came up repeatedly as actionable advice.
Deeper reflections matter too: Beyond the protocol talk, the thread became a space for philosophical and spiritual insight — a reminder that the cancer journey is both practical and profoundly human.

Original Post

2 comments